Article
Leveraging a holistic understanding of inhaled and nasal drugs, devices and combination products, our dedicated team can foresee challenges and ensure a smooth route to commercialisation.
From complex powder formulations for DPIs to solution and suspension products for pMDIs, we provide specialist development services supported by more than 60 years of experience.
Every innovation is unique. That’s why we offer bespoke solutions, whether you’re developing a new molecule or reformulating an existing therapy for a novel device or administration route.
For customers seeking additional capacity or a seamless path to scale-up, our technology transfer services support reliable, efficient project delivery that meets your unique technical, regulatory, and operational needs.
From cutting-edge biologics to highly customised delivery devices, we tailor our approach to meet your requirements and help bring your therapy to patients with confidence.
To help you navigate the regulatory process, our team of experts can provide insight and support, including regulatory strategy and submission writing. In addition, our regulatory teams benefit from hands-on technical experience, strengthening our approach to drug product development and regulatory submission. We also offer support across New Drug Applications (NDA), 505(b)(2), and generic pathways (ANDA) for a variety of platforms and formulations.